FEUTEL herbal combination to reduce HIV replicatio
Early Phase 1
Completed
- Conditions
- HIV.Asymptomatic human immunodeficiency virus [HIV] infection status
- Registration Number
- IRCT2016071929000N1
- Lead Sponsor
- Vice Chancellor for Research and Technology University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
The main criteria for selection of patients: patients who were not taken any medications before and during the study. Patients will take the drug twice a day with an interval of 12 hours. Exclusion criteria: those who doesn’t follow the strategy or plan.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method